Does Permanent Pacemaker Status Confer Mortality Benefit in the Short Term Post TAVI

Royal Sussex County Hospital

Status: Unknown

Conditions: TAVI

Treatments: Device: Pacemaker

Study type: Observational

Funder types: Other

Identifiers

NCT02700633

TAVIPPMEarlyMortality

Details and patient eligibility

About

Pacemaker requirement in the immediate post procedure phase following TAVI is approximately 20% depending on device type and patient characteristics. There is a signal from recent studies suggesting increased risk of sudden cardiac / unexplained death in the first 30-60 days. This study aims to address whether there is a mortality advantage to having a pacemaker in the short term

Enrollment: 4,000 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients post TAVI

Exclusion criteria

• Nil

Trial design

4,000 participants in 2 patient groups

Those with pacemaker at discharge

Description:

Landmark analysis of early mortality dependant on pacemaker status at discharge

Treatment:

Device: Pacemaker

Those without pacemaker at discharge

Description:

Landmark analysis of early mortality dependant on pacemaker status at discharge